Reaction
Hepatic Atrophy reporting signals
As of the last recalculation, Hepatic Atrophy appears in 444 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BEVACIZUMAB (PRR 53.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bevacizumab | 107 | 53.0 | 53.1 |
| Paclitaxel (Aibumin-Bound) | 68 | 45.6 | 45.7 |
| Paclitaxel | 70 | 39.2 | 39.2 |
| Pyrazinamide | 6 | 30.3 | 30.4 |
| Rifampicin | 6 | 28.2 | 28.2 |
| Regorafenib | 6 | 24.5 | 24.6 |
| Oxaliplatin | 28 | 18.8 | 18.8 |